Topic: graft-versus-host disease
Mallinckrodt and Transimmune hope to expand the applications of extracorporeal photopheresis to several new indications.
The week’s biotech news included a potential boost to cancer immunotherapy and new insight into a dementia-causing protein.
Kalytera is developing cannabidiol for the prevention and treatment of graft-versus-host disease, a serious complication of bone marrow transplant.
The FDA lifted a clinical hold it placed on Bellicum's lead cell therapy, BPX-501, in January.
A late-stage study of Mesoblast’s off-the-shelf stem cell therapy for acute graft-versus-host disease (GVHD) has hit its main goal, setting up an imminent U.S. filing.
Ocugen has raised $7.5 million in a series B round as it fixes its sights on advancing a trio of eye disease treatments into clinical trials.
Adienne is planning an IPO in Switzerland to fund the advance if its graft-versus-host disease drug over the regulatory finish line.